ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,333Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 617

$997K Total Retail Price of All Prescriptions

Rank: 4 out of 617

406 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 10,999 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
AMLODIPINE BESYLATE 802 615 1 6
ATORVASTATIN CALCIUM 387 302 2 8
SIMVASTATIN 381 337 3 3
ENALAPRIL MALEATE 378 326 4 22
METOPROLOL SUCCINATE 363 286 5 1
DIGOXIN 358 332 6 12
LEVOTHYROXINE SODIUM 355 315 7 23
ZETIA 345 256 8 24
FUROSEMIDE 340 270 9 7
CLOPIDOGREL 337 287 10 10
HYDRALAZINE HCL 280 230 11 28
PLAVIX 268 223 12 13
METFORMIN HCL 225 167 13 25
DIOVAN 219 183 14 21
WARFARIN SODIUM 209 198 15 9
METOPROLOL TARTRATE 194 160 16 5
NEXIUM 190 158 17 61
PRAZOSIN HCL 186 157 18 119
FENOFIBRATE 185 122 19 34
POTASSIUM CHLORIDE 182 154 20 19
ISOSORBIDE MONONITRATE ER 167 146 21 14
AMIODARONE HCL 167 146 21 27
CRESTOR 165 146 23 11
BYSTOLIC 164 137 24 29
CARVEDILOL 148 121 25 4
RANEXA 144 79 26 46
CELEBREX 136 101 27 131
LOSARTAN POTASSIUM 120 84 28 16
COLESTIPOL HCL 116 98 29 174
CARTIA XT 116 106 29 92
LISINOPRIL 111 92 31 2
TAMSULOSIN HCL 107 85 32 59
GLIPIZIDE ER 103 99 33 104
DIOVAN HCT 99 73 34 53
NIASPAN 95 72 35 35
JANUVIA 92 73 36 73
NIFEDIPINE ER 90 78 37 49
PEN NEEDLE 81 64 38 158
METOCLOPRAMIDE HCL 80 66 39 109
FAMOTIDINE 78 77 40 44
ALLOPURINOL 77 71 41 50
OMEPRAZOLE 77 63 41 31
NAPROXEN 76 49 43 98
GLIPIZIDE 73 63 44 64
TRILIPIX 72 48 45 90
LANTUS SOLOSTAR 72 56 45 200
ADVAIR DISKUS 72 52 45 87
ATENOLOL 72 72 45 17
CLONIDINE HCL 71 61 49 45
SINGULAIR 69 39 50 85
PROAIR HFA 67 49 51 97
DILTIAZEM 24HR ER 65 45 52 78
LANTUS 64 41 53 80
LIPITOR 63 47 54 66
HYDROCHLOROTHIAZIDE 61 58 55 18
GABAPENTIN 60 53 56 52
VERAPAMIL ER 60 57 56 107
CARBIDOPA-LEVODOPA 60 60 56 139
LEVEMIR FLEXPEN 56 53 59 217
BENICAR 56 39 59 82
METHYLDOPA 54 42 R 61 220
SPIRIVA 53 49 62 130
AMITRIPTYLINE HCL 52 51 R 63 154
IBUPROFEN 52 43 63 114
MECLIZINE HCL 51 51 65 94
TRICOR 51 39 65 75
VENTOLIN HFA 50 49 67 148
LOVASTATIN 50 46 67 41
LOVAZA 50 34 67 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.